Report Detail

Pharma & Healthcare Global and United States Viral Vaccines Market Insights, Forecast to 2026

  • RnM4190560
  • |
  • 04 September, 2020
  • |
  • Global
  • |
  • 133 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Viral Vaccines Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Viral Vaccines Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Viral Vaccines Market Size Growth Rate by Type
    • 1.4.2 Attenuated Vaccine
    • 1.4.3 Inactivated Vaccine
  • 1.5 Market by Application
    • 1.5.1 Global Viral Vaccines Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Pharmaceutical Factory
    • 1.5.4 Research Institute
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Viral Vaccines Market Size, Estimates and Forecasts
    • 2.1.1 Global Viral Vaccines Revenue 2015-2026
    • 2.1.2 Global Viral Vaccines Sales 2015-2026
  • 2.2 Global Viral Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Viral Vaccines Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Viral Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Viral Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Viral Vaccines Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Viral Vaccines Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Viral Vaccines Revenue Forecast by Region (2021-2026)

3 Global Viral Vaccines Competitor Landscape by Players

  • 3.1 Global Top Viral Vaccines Sales by Manufacturers
    • 3.1.1 Global Viral Vaccines Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Viral Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Viral Vaccines Manufacturers by Revenue
    • 3.2.1 Global Viral Vaccines Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Viral Vaccines Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Viral Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Viral Vaccines Revenue in 2019
    • 3.2.5 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Viral Vaccines Price by Manufacturers
  • 3.4 Global Viral Vaccines Manufacturing Base Distribution, Product Types
    • 3.4.1 Viral Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Viral Vaccines Product Type
    • 3.4.3 Date of International Manufacturers Enter into Viral Vaccines Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Viral Vaccines Market Size by Type (2015-2020)
    • 4.1.1 Global Viral Vaccines Sales by Type (2015-2020)
    • 4.1.2 Global Viral Vaccines Revenue by Type (2015-2020)
    • 4.1.3 Viral Vaccines Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Viral Vaccines Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Viral Vaccines Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Viral Vaccines Revenue Forecast by Type (2021-2026)
    • 4.2.3 Viral Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Viral Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Viral Vaccines Market Size by Application (2015-2020)
    • 5.1.1 Global Viral Vaccines Sales by Application (2015-2020)
    • 5.1.2 Global Viral Vaccines Revenue by Application (2015-2020)
    • 5.1.3 Viral Vaccines Price by Application (2015-2020)
  • 5.2 Viral Vaccines Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Viral Vaccines Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Viral Vaccines Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Viral Vaccines Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Viral Vaccines Market Size YoY Growth 2015-2026
    • 6.1.1 United States Viral Vaccines Sales YoY Growth 2015-2026
    • 6.1.2 United States Viral Vaccines Revenue YoY Growth 2015-2026
    • 6.1.3 United States Viral Vaccines Market Share in Global Market 2015-2026
  • 6.2 United States Viral Vaccines Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Viral Vaccines Players by Sales (2015-2020)
    • 6.2.2 United States Top Viral Vaccines Players by Revenue (2015-2020)
  • 6.3 United States Viral Vaccines Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Viral Vaccines Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Viral Vaccines Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Viral Vaccines Price by Type (2015-2020)
  • 6.4 United States Viral Vaccines Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Viral Vaccines Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Viral Vaccines Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Viral Vaccines Price Forecast by Type (2021-2026)
  • 6.5 United States Viral Vaccines Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Viral Vaccines Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Viral Vaccines Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Viral Vaccines Price by Application (2015-2020)
  • 6.6 United States Viral Vaccines Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Viral Vaccines Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Viral Vaccines Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Viral Vaccines Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Viral Vaccines Market Size YoY Growth 2015-2026
  • 7.2 North America Viral Vaccines Market Facts & Figures by Country
    • 7.2.1 North America Viral Vaccines Sales by Country (2015-2020)
    • 7.2.2 North America Viral Vaccines Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Viral Vaccines Market Size YoY Growth 2015-2026
  • 8.2 Europe Viral Vaccines Market Facts & Figures by Country
    • 8.2.1 Europe Viral Vaccines Sales by Country
    • 8.2.2 Europe Viral Vaccines Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Viral Vaccines Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Viral Vaccines Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Viral Vaccines Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Viral Vaccines Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Viral Vaccines Market Size YoY Growth 2015-2026
  • 10.2 Latin America Viral Vaccines Market Facts & Figures by Country
    • 10.2.1 Latin America Viral Vaccines Sales by Country
    • 10.2.2 Latin America Viral Vaccines Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Viral Vaccines Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Viral Vaccines Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Viral Vaccines Sales by Country
    • 11.2.2 Middle East and Africa Viral Vaccines Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 GSK
    • 12.1.1 GSK Corporation Information
    • 12.1.2 GSK Description and Business Overview
    • 12.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 GSK Viral Vaccines Products Offered
    • 12.1.5 GSK Recent Development
  • 12.2 Merck
    • 12.2.1 Merck Corporation Information
    • 12.2.2 Merck Description and Business Overview
    • 12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Merck Viral Vaccines Products Offered
    • 12.2.5 Merck Recent Development
  • 12.3 Novartis
    • 12.3.1 Novartis Corporation Information
    • 12.3.2 Novartis Description and Business Overview
    • 12.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Novartis Viral Vaccines Products Offered
    • 12.3.5 Novartis Recent Development
  • 12.4 Pfizer
    • 12.4.1 Pfizer Corporation Information
    • 12.4.2 Pfizer Description and Business Overview
    • 12.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Pfizer Viral Vaccines Products Offered
    • 12.4.5 Pfizer Recent Development
  • 12.5 Sanofi
    • 12.5.1 Sanofi Corporation Information
    • 12.5.2 Sanofi Description and Business Overview
    • 12.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Sanofi Viral Vaccines Products Offered
    • 12.5.5 Sanofi Recent Development
  • 12.6 Bayer
    • 12.6.1 Bayer Corporation Information
    • 12.6.2 Bayer Description and Business Overview
    • 12.6.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Bayer Viral Vaccines Products Offered
    • 12.6.5 Bayer Recent Development
  • 12.7 Zoetis
    • 12.7.1 Zoetis Corporation Information
    • 12.7.2 Zoetis Description and Business Overview
    • 12.7.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Zoetis Viral Vaccines Products Offered
    • 12.7.5 Zoetis Recent Development
  • 12.8 AstraZeneca
    • 12.8.1 AstraZeneca Corporation Information
    • 12.8.2 AstraZeneca Description and Business Overview
    • 12.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 AstraZeneca Viral Vaccines Products Offered
    • 12.8.5 AstraZeneca Recent Development
  • 12.9 Johnson
    • 12.9.1 Johnson Corporation Information
    • 12.9.2 Johnson Description and Business Overview
    • 12.9.3 Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Johnson Viral Vaccines Products Offered
    • 12.9.5 Johnson Recent Development
  • 12.10 CSL
    • 12.10.1 CSL Corporation Information
    • 12.10.2 CSL Description and Business Overview
    • 12.10.3 CSL Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 CSL Viral Vaccines Products Offered
    • 12.10.5 CSL Recent Development
  • 12.11 GSK
    • 12.11.1 GSK Corporation Information
    • 12.11.2 GSK Description and Business Overview
    • 12.11.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 GSK Viral Vaccines Products Offered
    • 12.11.5 GSK Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Viral Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Viral Vaccines Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Viral Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Viral Vaccines market is segmented into
    Attenuated Vaccine
    Inactivated Vaccine

    Segment by Application, the Viral Vaccines market is segmented into
    Hospital
    Pharmaceutical Factory
    Research Institute
    Others

    Regional and Country-level Analysis
    The Viral Vaccines market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Viral Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Viral Vaccines Market Share Analysis
    Viral Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Viral Vaccines business, the date to enter into the Viral Vaccines market, Viral Vaccines product introduction, recent developments, etc.
    The major vendors covered:
    GSK
    Merck
    Novartis
    Pfizer
    Sanofi
    Bayer
    Zoetis
    AstraZeneca
    Johnson
    CSL


    Summary:
    Get latest Market Research Reports on Viral Vaccines. Industry analysis & Market Report on Viral Vaccines is a syndicated market report, published as Global and United States Viral Vaccines Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Viral Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,984.58
    4,476.88
    5,969.17
    3,292.70
    4,939.04
    6,585.39
    408,408.00
    612,612.00
    816,816.00
    287,328.60
    430,992.90
    574,657.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report